Margaret G. McGlynn, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,000 shares at $280.19 ($1.4M) on 2022-04-08, disclosed to the SEC on 2022-04-12.
Open-market sale of $1.4M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $280.19 | 4,900 | $1.4M | 98.0% |
| 2 | $281.49 | 100 | $28K | 2.0% |
| Total | $280.22 avg | 5,000 | $1.4M | 100% |
| Filing → |
| FOLD | SELL | 2022-05-04 | $105K | — | Filing → |
| VRTX | SELL | 2022-04-04 | $2.6M | — | Filing → |
| VRTX | SELL | 2022-02-01 | $2.2M | — | Filing → |